Dosing underway in BioTime dry AMD trial

The first patient has been dosed in an ongoing phase 1/2a clinical trial with a new thaw-and-inject formulation of OpRegen, delivered with the Orbit subretinal delivery system, BioTime announced in a press release.The open-label, dose escalation trial …

Custom 3D Printed Robotic Surgical Instruments for Every Patient

Today’s arthroscopic instruments that are used to perform minimally invasive procedures on hips, knees, and other parts of the body, are rigid devices. They also tend to be one-size-fits-all solutions that surgeons have to use on patients with varied anatomies. Now, a team at the Australian Centre for Robotic Vision are working on being able (Read more...)